Form 8-K - Current report:
SEC Accession No. 0001104659-26-084095
Filing Date
2026-07-16
Accepted
2026-07-16 08:35:13
Documents
14
Period of Report
2026-07-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20260716x8k.htm   iXBRL 8-K 57208
2 EX-10.1 hrmy-20260716xex10d1.htm EX-10.1 238918
3 EX-99.1 hrmy-20260716xex99d1.htm EX-99.1 16088
4 GRAPHIC hrmy-20260716xex99d1001.jpg GRAPHIC 10901
  Complete submission text file 0001104659-26-084095.txt   479048

Data Files

Seq Description Document Type Size
5 EX-101.SCH hrmy-20260716.xsd EX-101.SCH 2709
6 EX-101.LAB hrmy-20260716_lab.xml EX-101.LAB 15924
7 EX-101.PRE hrmy-20260716_pre.xml EX-101.PRE 10077
17 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20260716x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 261178751
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)